ProQR Therapeutics (PRQR) Change in Cash (2013 - 2026)

ProQR Therapeutics has reported Change in Cash for 14 years, with the latest figure at -$13.6 million in Q1 2026.

• Quarterly Change in Cash rose 21.77% year-over-year to -$13.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$58.8 million (down 216.95% YoY) and the FY2025 annual result came in at -$64.8 million, down 303.35% from the prior year.
• Change in Cash advanced to -$13.6 million in Q1 2026 per PRQR's latest filing, from -$16.9 million in the prior quarter.
• Over five years, Change in Cash peaked at $63.4 million in Q4 2024 and troughed at -$59.9 million in Q3 2022.
• A 5-year average of -$7.3 million and a median of -$13.4 million in 2025 frame the typical range for Change in Cash.
• The sharpest annual moves came in 2022 and 2024: Change in Cash sank 431.09% in 2022, then soared 4264.73% in 2024.
• Over 5 years, Change in Cash stood at -$4.1 million in 2022, then surged by 63.18% to -$1.5 million in 2023, then jumped by 4264.73% to $63.4 million in 2024, then slumped by 126.61% to -$16.9 million in 2025, then gained by 19.35% to -$13.6 million in 2026.
• According to Business Quant data, Change in Cash over the past three periods registered -$13.6 million, -$16.9 million, and -$15.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.